Read the latest reports on Western Europe, with local insight, sp...
Read the latest reports on Western Europe, with local insight, specialist knowledge and a comprehensive breakdown of key market data. Our research identifies key strategic themes relevant across the region, while also providing a more granular unders...
Paediatric consumer health is performing well in 2023 for the second consecutive year, albeit at a much lower pace of current value growth than in 2022. Ireland witnessed a more intense season of common colds and viruses among children in 2022 as the…
Paediatric consumer health is expected to see strong growth in current value terms in 2023, with most categories projected to post a positive performance in value and volume terms. Volume sales are benefiting from the increase in unit prices…
The sales performances recorded in each of the categories that comprise paediatric consumer health during 2023 were determined to some extent by the performances recorded in each of these categories in 2020, during the early stages of the COVID-19…
Paediatric consumer health is still a small category in Portugal with parents/guardians generally preferring to buy products on prescription. Portuguese parents/guardians perceive there to be a higher risk when it comes to their children and will…
Spain’s birth rate continues to fall, thereby reducing the target audience of paediatric consumer health and compounding declining growth rates in 2023. As there are no national policies to support a rise in the country’s birth rate, this trend is…
Paediatric consumer health remains a minor part of total consumer health in Sweden. The key reasons for this low share include the fact that children are usually treated with general products (suitable for adults and children) with the appropriate…
Value sales of paediatric consumer health remains positive in 2023. Swiss parents prefer to consult with their health practitioner when it comes to their children, and seek help from professionals before resorting to medical recommendations that lead…
Over 2023, paediatric consumer health retail current value sales are expected to continue to grow healthily. On the other hand, retail volume development is projected to be marginal-to-moderate, with declines anticipated for paediatric acetaminophen…
Paediatric consumer health in the UK is witnessing another strong year of current value growth in 2023, albeit at a slower pace than 2022. The positive performance across both years has predominantly been driven by high growth for paediatric cough,…
In general, paediatric consumer health recorded strong retail volume growth during the early-to-mid-review period, with the outbreak of Coronavirus (COVID-19) in 2020 providing a particular fillip to demand. However, as the pandemic threat eased, the…
Retail volume sales of sleep aids are declining for the second year running in 2023. The outbreak of COVID-19 led to increased levels of fear and anxiety in 2020 and 2021 which helped drive record sales of sleep aids. With conditions improving in…
Sales of sleep aids are seeing more stable growth in 2023 after the peaks achieved in 2020-2021 when the pandemic created widespread anxiety and insomnia. Many people had to work from home and home-school their children during times of lockdown and…
Sleep aids is expected to register moderate current value growth and a slight increase in volume sales in 2023. The war in Ukraine and the resulting energy crisis are pushing up average retail prices. While Danes are now much less concerned about the…
Sleep aids sales are set to see continued growth in 2023. The major disruptions to lifestyles and the increasing economic pressures experienced in the last few years have led to a significant increase in the incidence of stress and anxiety and…
Demand for sleep aids remains high in 2023. Since the pandemic, an increase in sleep issues due to anxiety, depression, and stress, has spread among a large proportion of the French population. According to Euromonitor International’s Voice of the…
As in 2022, sleep aids was registering a slight decline in current value terms as a result of falling in 2023. While prices were still rising during the pandemic (2020, 2021), which, paired with increased volume demand for sleep aids during the…
The key growth driver in sleep aids in terms of ingredients is melatonin. The variety and availability of products based on melatonin increased dramatically at the end of the review period. The launch of Procter & Gamble’s ZzzQuil Nature made a…
General anxiety related to economic uncertainty, the high cost of living and the war in Ukraine is improving the popularity of sleep aids in 2023. Many consumers are also back to hectic everyday lifestyles, with commuting, longer working hours and a…
Sales of sleep aids continue to decline in 2023 in current value and retail volume terms, following the trend observed in the previous year. Sales of sleep aids soared in 2020 and 2021 following the outbreak of COVID-19 with the pandemic resulting in…
Sleep aids continued to register positive growth in volume sales in 2023 as the stress that increasing numbers of local consumers now face in their lives continued to take its toll on the nation’s sleep patterns. High stress levels are primarily the…